Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $39.0800 (-3.71%) ($39.0800 - $39.0800) on Fri. Sep. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.31% (three month average) | RSI | 36 | Latest Price | $39.0800(-3.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO declines -3.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(74%) IVE(51%) XRT(40%) XME(36%) FIVG(35%) | Factors Impacting HALO price | HALO will decline at least -1.155% in a week (0% probabilities). VXX(-34%) XHB(-25%) INDA(-90%) IPO(-24%) TBT(-21%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.155% (StdDev 2.31%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $31.73(-18.81%) | Resistance Level | $41.21 | 5 Day Moving Average | $39.44(-0.91%) | 10 Day Moving Average | $39.91(-2.08%) | 20 Day Moving Average | $41.21(-5.17%) | To recent high | -11.3% | To recent low | 14.5% | Market Cap | $5.341b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |